Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,207 | -20,040 | -25,111 | -24,961 | -8,949 |
| Depreciation Amortization | 3,719 | 2,707 | 5,828 | 5,955 | 882 |
| Accounts receivable | -3,361 | -3,001 | -1,942 | 2,211 | -1,292 |
| Other Working Capital | -5,674 | 1,619 | 908 | -1,090 | -320 |
| Other Operating Activity | 300 | 3,516 | 2,440 | 1,881 | 2,942 |
| Operating Cash Flow | $-19,223 | $-15,199 | $-17,877 | $-16,004 | $-6,737 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 20,422 | -12,642 | -7,780 | 71 |
| PPE Investments | -4,402 | -15,054 | -16,575 | -3,563 | -457 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 1,325 |
| Investing Cash Flow | $-4,402 | $5,368 | $-29,217 | $-11,343 | $939 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,592 | 7,149 | 3,345 | 572 | 221 |
| Debt Repayment | -993 | -284 | -159 | -473 | N/A |
| Common Stock Issued | 25,312 | 7,909 | 25,504 | 16,381 | N/A |
| Other Financing Activity | 0 | -9,768 | 22,000 | 14,902 | 12,620 |
| Financing Cash Flow | $28,911 | $5,006 | $50,690 | $31,382 | $12,841 |
| Beginning Cash Position | 10,219 | 15,044 | 11,448 | 7,413 | 370 |
| End Cash Position | 15,505 | 10,219 | 15,044 | 11,448 | 7,413 |
| Net Cash Flow | $5,286 | $-4,825 | $3,596 | $4,035 | $7,043 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,223 | -15,199 | -17,877 | -16,004 | -6,737 |
| Capital Expenditure | -4,402 | -15,054 | -16,575 | -3,563 | -457 |
| Free Cash Flow | -23,625 | -30,253 | -34,452 | -19,567 | -7,194 |